01 January 1970 3 7K Report

Breast cancer continues to pose a significant global challenge to women's health. Fortunately, with the continuous progress in science and technology, our understanding of the disease and treatment methods has been deepening. As a dedicated cancer research journal, Oncology Research is committed to disseminating the latest advancements in breast cancer research. Our goal is to empower patients, physicians, and researchers with the knowledge necessary to better understand and respond to this serious disease.

Over the past two years, we have proudly published a series of pivotal breast cancer research papers, showcasing exceptional work from renowned scientists worldwide. With rigorous screening, our team has curated a selection of significant papers on breast cancer published between 2022 and 2023. These articles encompass a wide range of aspects, including early diagnosis, personalized treatment, immunotherapy, and more. By delving into these innovative studies, we aim to provide valuable insights into breast cancer development, novel treatment approaches, and preventive strategies.

Join us in exploring these cutting-edge research findings, enabling us to collectively advance our knowledge and make meaningful progress in combating breast cancer.

01.Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities

GANG WANG, MINGPING QIAN, WEI JIAN, JUHANG CHU, YIXIANG HUANG*

https://www.techscience.com/or/v31n1/51754

02.An inflammatory-related genes signature based model for prognosis prediction in breast cancer

JINGYUE FU, RUI CHEN, ZHIZHENG ZHANG, JIANYI ZHAO, TIANSONG XIA*

https://www.techscience.com/or/v31n2/52294

03.Targeting triple-negative breast cancer: A clinical perspective

LAZAR S. POPOVIC*, GORANA MATOVINA-BRKO, MAJA POPOVIC, KEVIN PUNIE, ANA CVETANOVIC, MATTEO LAMBERTINI

https://www.techscience.com/or/v31n3/52821

04.Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients

FRANCISCO RAÚL BORZONE*, MARÍA BELÉN GIORELLO, LEANDRO MARCELO MARTINEZ, MARÍA CECILIA SANMARTIN, LEONARDO FELDMAN, FEDERICO DIMASE, EMILIO BATAGELJ, GUSTAVO YANNARELLI, NORMA ALEJANDRA CHASSEING*

https://www.techscience.com/or/v31n3/52818

05.The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway

SHUIZHONG CEN, XIAOJIE PENG, JIANWEN DENG, HAIYUN JIN, ZHINAN DENG, XIAOHUA LIN, DI ZHU, MING JIN6, YANWEN ZHU, PUSHENG ZHANG, YUNFENG LUO, HONGYAN HUANG*

https://www.techscience.com/or/v31n3/52820

06.Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer

GUODONG XIAO, FENG CHENG1, JING YUAN1, WEIPING LU1, PEILI WANG2, HUIJIE FAN1*

https://www.techscience.com/or/v30n1/50707

07.circRNAs in drug resistance of breast cancer

SEMA MISIR*, SERAP OZER YAMAN, NINA PETROVIĆ, CEREN SUMER, CEYLAN HEPOKUR, YUKSEL ALIYAZICIOGLU

https://www.techscience.com/or/v30n4/51394

08.The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients

NADIA Z. SHAABAN, NASHWA K. IBRAHIM, HELEN N. SAADA, FATMA H. EL-RASHIDY, HEBATALLAH M. SHAABAN, NERMEEN M. ELBAKARY*, AHMAD S. KODOUS*

https://www.techscience.com/or/v30n6/51595

Thank you for your time.

Sincerely,

Oncology Research Editorial

Contact Us:

871 Coronado Center Drive, Suite 200,

Henderson, Nevada, 89052, US

Tel: +1 702 673 0457

Fax: +1 844 635 2598

Office Hours: 9:00-17:00 (UTC -8:00)

[email protected]

More Elaine Lu's questions See All
Similar questions and discussions